Barinthus Biotherapeutics Proxy Statement Filed
Ticker: BRNS · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1828185
| Field | Detail |
|---|---|
| Company | Barinthus Biotherapeutics PLC. (BRNS) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance, executive-compensation
TL;DR
Barinthus proxy filed - vote on exec pay & board for 2024.
AI Summary
Barinthus Biotherapeutics plc filed a DEF 14A proxy statement on April 25, 2025, for its annual meeting on June 10, 2025. The filing details executive compensation, board nominations, and other corporate governance matters for the fiscal year ending December 31, 2024. Key individuals mentioned include members of the board such as Enright, Brown, and Griffiths.
Why It Matters
This filing provides shareholders with crucial information regarding the company's leadership, compensation, and voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual proxy filing with no immediate material events indicated.
Key Numbers
- 20250425 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 20250610 — Meeting Date (Date of the shareholder meeting for which this proxy statement is issued.)
- 2024-12-31 — Fiscal Year End (The period covered by the financial information in the proxy statement.)
Key Players & Entities
- Barinthus Biotherapeutics plc (company) — Filer of the DEF 14A
- Enright (person) — Board Member
- Brown (person) — Board Member
- Griffiths (person) — Board Member
- Vaccitech plc (company) — Former company name
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit shareholder votes on important matters such as the election of directors, executive compensation, and other corporate actions.
When is the shareholder meeting for which this proxy statement is filed?
The shareholder meeting is scheduled for June 10, 2025.
Who are some of the individuals listed as board members in this filing?
Individuals listed as board members include Enright, Brown, and Griffiths.
What was Barinthus Biotherapeutics plc formerly known as?
Barinthus Biotherapeutics plc was formerly known as Vaccitech plc.
What is the fiscal year end for the reporting period?
The fiscal year end for the reporting period is December 31, 2024.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 by Enright regarding Barinthus Biotherapeutics plc. (BRNS).